Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DDAVP challenge tests in boys with mild/moderate haemophilia A.
Revel-Vilk S, Blanchette VS, Sparling C, Stain AM, Carcao MD. Revel-Vilk S, et al. Among authors: blanchette vs. Br J Haematol. 2002 Jun;117(4):947-51. doi: 10.1046/j.1365-2141.2002.03507.x. Br J Haematol. 2002. PMID: 12060135 Free article.
Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.
Revel-Vilk S, Schmugge M, Carcao MD, Blanchette P, Rand ML, Blanchette VS. Revel-Vilk S, et al. Among authors: blanchette p, blanchette vs. J Pediatr Hematol Oncol. 2003 Nov;25(11):874-9. doi: 10.1097/00043426-200311000-00010. J Pediatr Hematol Oncol. 2003. PMID: 14608197
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon MC, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS. Feldman BM, et al. Among authors: blanchette vs. Lancet Haematol. 2018 Jun;5(6):e252-e260. doi: 10.1016/S2352-3026(18)30048-6. Epub 2018 May 3. Lancet Haematol. 2018. PMID: 29731369
Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?
Carcao MD, Chelle P, Clarke E, Kim L, Tiseo L, Morfini M, Hossain T, Rand ML, Brown C, Edginton AN, Lillicrap D, Iorio A, Blanchette VS. Carcao MD, et al. Among authors: blanchette vs. J Thromb Haemost. 2019 Jul;17(7):1085-1096. doi: 10.1111/jth.14469. Epub 2019 Jun 2. J Thromb Haemost. 2019. PMID: 31038793 Free article.
Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool.
Carcao M, Zunino L, Young NL, Dover S, Bouskill V, Hilliard P, Price VE, Blanchette VS. Carcao M, et al. Among authors: blanchette vs. Haemophilia. 2020 Jan;26(1):73-78. doi: 10.1111/hae.13905. Epub 2019 Dec 22. Haemophilia. 2020. PMID: 31865620
Genotype-phenotype correlation in children with hereditary spherocytosis.
Tole S, Dhir P, Pugi J, Drury LJ, Butchart S, Fantauzzi M, Langer JC, Baker JM, Blanchette VS, Kirby-Allen M, Carcao MD. Tole S, et al. Among authors: blanchette vs. Br J Haematol. 2020 Nov;191(3):486-496. doi: 10.1111/bjh.16750. Epub 2020 May 20. Br J Haematol. 2020. PMID: 32436265 Free article.
312 results